Ignite Creation Date:
2025-12-24 @ 7:38 PM
Ignite Modification Date:
2026-01-18 @ 10:18 PM
Study NCT ID:
NCT02827903
Status:
COMPLETED
Last Update Posted:
2018-07-06
First Post:
2016-06-23
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Metformin/Rosuvastatin Combination Therapy With in Patients With Type 2 Diabetes and Dyslipidemia
Sponsor:
Jeil Pharmaceutical Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-01-15
Start Date Type:
ACTUAL
Primary Completion Date:
2017-11-21
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-03-16
Completion Date Type:
ACTUAL
First Submit Date:
2016-06-23
First Submit QC Date:
None
Study First Post Date:
2016-07-11
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-07-05
Last Update Post Date:
2018-07-06
Last Update Post Date Type:
ACTUAL